Last reviewed · How we verify
17 B estradiol orally
At a glance
| Generic name | 17 B estradiol orally |
|---|---|
| Also known as | Estrace |
| Sponsor | Nemours Children's Clinic |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Drug-Drug Interaction Study in Trans Women Living With HIV (PHASE4)
- Estrogen Dosing in Turner Syndrome: Pharmacology and Metabolism (PHASE4)
- Estrogen, Probiotics and Vaginal Health to Prevent HIV Infection in ACB Women (PHASE1)
- Effect of Antidepressants on Sex Hormone Levels and Sexual Functioning (PHASE4)
- A Study to Evaluate the Acceptability and Preference for Contraceptive Options as Proxy for HIV Prevention Methods (NA)
- Comparison of Vascular Findings Between Symptomatic and Asymptomatic Postmenopausal Women Before and During Hormone Therapy (HRT) (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- 17 B estradiol orally CI brief — competitive landscape report
- 17 B estradiol orally updates RSS · CI watch RSS
- Nemours Children's Clinic portfolio CI